These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38282636)

  • 1. A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials.
    Sabu ST; Venkatraman S; Cherian JJ; Das S; Pahuja M; Adhikari T; Mukherjee S; Chatterjee NS; Kshirsagar NA
    Perspect Clin Res; 2024; 15(1):18-23. PubMed ID: 38282636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
    Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O
    BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020.
    Shree Devi MS; Sathiyarajeswaran P; Kanakavalli K; Vinod NP; Baskar V
    J Ayurveda Integr Med; 2021; 12(2):346-350. PubMed ID: 34024689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.
    Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R
    Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants.
    Malshe N; Palkar S; Kulkarni R; Lalwani S; Mishra AC; Arankalle V
    Vaccine; 2019 Mar; 37(11):1443-1448. PubMed ID: 30765170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for measles, mumps and rubella in children.
    Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
    Sharma H; Parekh S; Pujari P; Shewale S; Desai S; Bhatla N; Joshi S; Pimple S; Kawade A; Balasubramani L; Thomas A; Suri V; Lalwani S; Uday R; Kamath V; Mandal R; Rajeswar A; Peedicayil A; Poli UR; Banerjee D; Sankaranarayanan R; Basu P; Muwonge R; Gairola S; Dogar V; Rao H; Shaligram U
    Lancet Oncol; 2023 Dec; 24(12):1321-1333. PubMed ID: 37949086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigator knowledge, awareness, and registrations of academic clinical trials with the Clinical Trial Registry of India: An observational study.
    Bhide S; Patil S; Sohal A; Kadhe N; Munshi R; Phirke C; Ambre S; Pawar S; Patil R
    Perspect Clin Res; 2023; 14(4):187-193. PubMed ID: 38025286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial.
    Bavdekar A; Oswal J; Ramanan PV; Aundhkar C; Venugopal P; Kapse D; Miller T; McGray S; Zehrung D; Kulkarni PS;
    Vaccine; 2018 Feb; 36(9):1220-1226. PubMed ID: 29395526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries.
    Ndwandwe D; Runeyi S; Mathebula L; Wiysonge C
    Trials; 2022 Nov; 23(1):945. PubMed ID: 36397105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis.
    Schenk J; Abrams S; Theeten H; Van Damme P; Beutels P; Hens N
    Lancet Infect Dis; 2021 Feb; 21(2):286-295. PubMed ID: 32888410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated management of childhood illness (IMCI) strategy for children under five.
    Gera T; Shah D; Garner P; Richardson M; Sachdev HS
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD010123. PubMed ID: 27378094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety in FIH Trials: A Summary of the Symposium "Fatal Drug Trial in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost".
    Greenberg HE; van Iersel MT; Westrick ML; Smith WB
    Ther Innov Regul Sci; 2017 May; 51(3):276-284. PubMed ID: 30231706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.